Effects of Simvastatin on Uterine Leiomyoma Size

Status Recruiting

Clinical Trial Summary

The study aims to study the effect of simvastatin on the size of uterine fibroids.

Clinical Trial Description

The study is a phase II double blinded clinical trial to determine feasibility, safety and preliminary clinical efficacy of simvastatin to reduce leiomyoma size. Women with symptomatic fibroids planned to undergo surgical management for fibroids such as hysterectomy or myomectomy will be screened for participation. The eligible women will undergo pre-study evaluation to ascertain study eligibility.The study will enroll 60 participants in total, half will receive simvastatin and the other half will receive a placebo. The study drug and placebo will be an add on to the participants ongoing medical management of fibroids until surgery. The participants will be monitored at intervals for the effect of the drug on fibroid size and symptoms using ultrasound and quality of life questionnaires. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03400826
Study type	Interventional
Source	Johns Hopkins University
Contact	Mostafa Borahay, MD, PhD
Phone	(410) 550-0337
Email	mboraha1@jhmi.edu
Status	Recruiting
Phase	Phase 2
Start date	August 20, 2018
Completion date	December 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04172272` - The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures	N/A
Terminated	`NCT02940041` - Concordance Between Sonography Amd MRI for Presurgical Diagnosis of Uterine Mesenchymal Malignant Tumors
Withdrawn	`NCT00768742` - Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study	N/A
Completed	`NCT00152256` - A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids	Phase 3
Completed	`NCT00156195` - Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids	Phase 3
Completed	`NCT00160381` - A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids	Phase 3
Recruiting	`NCT04214457` - Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas
Completed	`NCT00044876` - Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist	Phase 2
Completed	`NCT02889848` - Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)	Phase 1
Recruiting	`NCT04145518` - Mechanistic Characterization of Uterine Pain	Phase 4
Completed	`NCT01816815` - Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670	Phase 1
Completed	`NCT00891657` - Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy	N/A
Completed	`NCT00156156` - Study of Asoprisnil in the Treatment of Uterine Fibroids.	Phase 3
Recruiting	`NCT05538689` - Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)	Phase 4
Active, not recruiting	`NCT03323905` - Single Arm Study Using the Symphony -- MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas	N/A
Terminated	`NCT03342859` - Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned	Phase 1
Recruiting	`NCT06135870` - Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
Completed	`NCT02777203` - Power Morcellation Systems for Laparoscopic Hysterectomy and Myomectomy	N/A
Completed	`NCT02189083` - Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine Fibroids	Phase 3
Completed	`NCT01123603` - Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine Leiomyomata	N/A